ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.07
2023-08-14 07:25:38 ET
- Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.28 misses by $0.07 .
- The company ended the second quarter with cash totaling $9.1 million compared to $9.1 million as of December 31, 2022.
For further details see:
Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.07